Acabrunat 100 Capsule 30's
Acabrunat 100 Capsule is used to treat Mantle cell lymphoma (MCL), chronic lymphocytic leukaemia (CLL) and small lymphocytic lymphoma (SLL). It contains Acalabrutinib, a tyrosine kinase inhibitor. Tyrosine kinases are enzymes in the body that transmit signals to cells, telling them to grow and divide. Acalabrutinib inhibits these signals to cancer cells. Cells die when their signals are disrupted. This could help to slow the progression of the cancer.
₹13640*
MRP ₹15500
12% off
₹13640*
MRP ₹15500
12% CB
₹1860 cashback(12%)
Free Delivery
With Circle membership
30 Capsule(Inclusive of all Taxes)
This offer price is valid on orders above ₹800. Apply coupon PHARMA10/PHARMA18 (excluding restricted items)
Provide Delivery Location
Whats That
Acabrunat 100 Capsule is a tyrosine kinase inhibitor or cancer growth inhibitor that is primarily used to treat people with mantle cell lymphoma (MCL) who have had at least one prior treatment for their malignancy (cancer), as well as adults with chronic lymphocytic leukaemia (CLL) or small lymphocytic lymphoma (SLL). Cancer is caused by a genetic mutation that causes our cells to divide uncontrollably and spread into neighbouring tissues.
Acabrunat 100 Capsule contains Acalabrutinib, a tyrosine kinase inhibitor. Tyrosine kinases are enzymes in the body that transmit signals to cells, telling them to grow and divide. Acalabrutinib inhibits these signals to cancer cells. Cells die when their signals are disrupted. This could help to slow the progression of the cancer.
To treat your condition effectually, continue using Acabrunat 100 Capsule for as long as your doctor has prescribed it. The most common adverse reactions are anaemia (lack of blood), neutropenia (low count of neutrophils), upper respiratory tract infection, thrombocytopenia (Low platelet level), headache, diarrhoea, and musculoskeletal pain. You should talk to your doctor if you persistently experience these side effects.
It is recommended not to use if you are hypersensitive to any component present in Acabrunat 100 Capsule and suffer from Severe Hepatic Impairment. Acabrunat 100 Capsule can cause fetal harm when administered to a pregnant woman. It is critical not to become pregnant or get pregnant while undergoing therapy and for several months after the treatment. Using effective contraceptive methods is recommended while on therapy with Acabrunat 100 Capsule . Contact your doctor immediately if you or your partner becomes pregnant while undergoing therapy. Breastfeeding is usually not advised during this treatment. Alcohol should be avoided during treatment with this medicine. Safety and effectiveness in children have not been established.
Acabrunat 100 Capsule is primarily used to treat people with mantle cell lymphoma (MCL) who have had at least one prior treatment for their malignancy, as well as adults with chronic lymphocytic leukaemia (CLL) or small lymphocytic lymphoma (SLL). Acabrunat 100 Capsule contains Acalabrutinib, a tyrosine kinase inhibitor. Tyrosine kinases are enzymes in the body that send signals to cells, directing them to grow and divide. Acalabrutinib blocks these signals to cancer cells. Cancer cells die when their signals are interrupted. This could help to delay the progression of the cancer.
Before taking the Acabrunat 100 Capsule , inform your doctor about all your medical conditions, sensitivities, and medications you are using. If you are a woman capable of having children, you should use an effective method of contraception during Acalabrutinib treatment and for at least one week after the last dose. If you are a man, you should use a barrier method of contraception to prevent your partner from becoming pregnant while taking Acalabrutinib and for at least one week after the last dose. Unless the doctor suggests, do not use any other medicine, including herbal or vitamin supplements.
Drug-Drug Interactions: Acabrunat 100 Capsule may interact with Blood thinner medications (e.g. abciximab, apixaban), Vaccinations (e.g. BCG vaccine), Nonsteroidal Anti-inflammatory drugs (e.g. bromfenac, ibuprofen), HIV medications (e.g. cobicistat), Anticancer medications (e.g. dasatinib), antifungal medications (e.g. fluconazole) and medicines decreasing the amount of acid made in the stomach (e.g. esomeprazole).
Drug-Food Interactions: Avoid the intake of alcoholic beverages, grapefruit and grapefruit juice.
Drug-Disease Interactions: Acabrunat 100 Capsule interacts with disease conditions, including arrhythmias, bleeding disorder, kidney or liver illness, infections (Bacterial/Fungal/Protozoal/Viral), Immunodeficiency, and Bone Marrow Depression/Low Blood Counts.
Cancer: Cancer is a genetic change in which our cells divide uncontrollably and spread into surrounding tissues. There are two types of cancer: benign (localized) and metastatic (spread to the whole body). Types of cancer include blood, lung, breast, etc. Cancer growth can be prevented by chemotherapy, radiation, and stem cell therapy.
Mantle Cell lymphoma (MCL): Mantle Cell lymphoma (MCL) is an aggressive, rare form of non-Hodgkin lymphoma (NHL) that arises from cells originating in the “mantle zone.” The mantle zone is the outer ring of small lymphocytes surrounding the centre of a lymphatic nodule.
Alcohol
Unsafe
Avoid alcohol consumption while on treatment with Acabrunat 100 Capsule .
Pregnancy
Unsafe
Acabrunat 100 Capsule should not be used during pregnancy. So, inform your doctor if you are pregnant or suspect pregnancy. You or your partner must use a reliable form of contraception to prevent pregnancy while taking these medications.
Breast Feeding
Unsafe
Acabrunat 100 Capsule should not be used in breastfeeding. Discuss with your doctor if you have any concerns.
Driving
Caution
Acabrunat 100 Capsule does not influence the ability to drive or use machines. However, go only if you are alert, as the Acabrunat 100 Capsule may cause tiredness in some people.
Liver
Caution
Avoid using Acabrunat 100 Capsule in patients with severe hepatic impairment. The safety of Acabrunat 100 Capsule has not been evaluated in patients with moderate or severe hepatic impairment. So, caution should be exercised while using Acabrunat 100 Capsule in patients with liver impairment. If you have a pre-existing or a history of liver disease, inform your doctor before taking the Acabrunat 100 Capsule . Your doctor will weigh the benefits and potential risks before prescribing Acabrunat 100 Capsule .
Kidney
Caution
Caution should be exercised while using Acabrunat 100 Capsule in patients with kidney impairment. If you have a pre-existing or a history of kidney disease, inform your doctor before taking the Acabrunat 100 Capsule . Your doctor will weigh the benefits and potential risks before prescribing Acabrunat 100 Capsule .
Children
Caution
Safety and effectiveness in patients below the age of 18 years have not been established. Hence, use is not recommended.
Country of origin
Manufacturer/Marketer address
We provide you with authentic, trustworthy and relevant information
Product Substitutes
1 Bottle